The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
(10 - 33) Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21.1 - Manufacture of basic pharmaceutical products
150 jobs Number of planned job creations
Announcement Date
17 June 2025
Employment effect (start)
1 July 2025
Foreseen end date
31 December 2025
Description
The Greek pharmaceutical company ELPEN, operating since 1965, plans to create at least 150 additional jobs by the end of 2025.
This employment growth will be driven by the company’s new industrial expansion in Keratea, which has been operational since 2023.
ELPEN also plans to invest €310 million over the next five years. These investments are expected to create an additional 1,500 permanent jobs across a wide range of specialities.
Subsidiary companies of ELPEN have been operating in Germany since 2012 and in Dubai since 2024. The company currently employs over 2,000 people across its group.
Eurofound (2025), Elpen, Business expansion in Greece, factsheet number 203061, European Restructuring Monitor. Dublin, https://dev.eurofound.europa.eu/restructuring-events/detail/203061.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
